Clinical Trial Update: Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response [Phase 4]

View source ↗

Summary

Phase 4 trial investigating neural, genetic, and peripheral biomarkers associated with SSRI response in depression; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SSRI (selective serotonin reuptake inhibitor) (selective serotonin reuptake inhibitor)

Snippet

Sponsor: Medical University of Vienna | Conditions: Depression | Phase 4 | Status: COMPLETED